Smoking and Periodontitis
On this page
Direct answer
A smoker's gingiva flatters to deceive: nicotine-driven vasoconstriction reduces redness, oedema and bleeding on probing, so the gums look quiet while attachment and bone disappear faster than in non-smokers — smokers are commonly quoted as several-fold more likely to develop severe periodontitis, with the risk rising dose-dependently by pack-years. Tobacco undermines every level of defence: impaired neutrophil function, suppressed fibroblast proliferation and collagen production, reduced gingival blood flow, an anaerobe-shifted flora, and diminished antibody and cytokine responses. Healing pays the same tax — smokers gain less attachment after therapy, flap surgery and grafts, and fail implants and regenerative procedures more often — and quitters recover risk partially, former smokers sitting between current and never-smokers. Indian practice adds the smokeless dimension: gutkha, paan masala and khaini placed against the gingiva cause localised recession and pocketing at the site, with leukoplakia and oral submucous fibrosis.
What you must remember
- Risk magnitude: current smokers have several-fold higher odds of severe periodontitis than never-smokers, scaling with pack-years — phrase as dose-dependent association in the exam.
- The deceptive clinical picture: reduced bleeding on probing, less erythema and oedema from vasoconstriction, masking inflammation while attachment and bone loss progress — a "clean-looking" mouth with deep pockets and heavy bone loss is a smoking signature until excluded.
- Host mechanisms to list: impaired neutrophil chemotaxis and phagocytosis, suppressed fibroblast replication and collagen synthesis, reduced immunoglobulin responses, and vasoconstriction lowering gingival blood flow.
- Microbial shift: smoking favours a more anaerobic, periodontopathogenic subgingival flora, with greater colonisation by Tannerella forsythia and Porphyromonas gingivalis.
- Healing penalty: reduced probing-depth and attachment gains after scaling, flap surgery, grafts and guided tissue regeneration; higher implant failure; more abscesses and tooth loss.
- Quitting pays: risk in former smokers falls between current and never-smokers, and quitting before surgery measurably improves healing — cessation advice is a clinical procedure, not a moral lecture.
- Smokeless tobacco in India: placement-site gingival recession and white lesions, attachment loss at the site, leukoplakia and oral submucous fibrosis — question every patient about gutkha, paan with tobacco and khaini by name.
- The 5A framework for cessation — ask, advise, assess, assist, arrange — structures the exam answer on tobacco cessation counselling.
Reading the smoker's chart
Examine a 44-year-old smoker of 20 cigarettes a day for 25 years: bleeding on probing at only 8 per cent of sites, yet generalised 7-8 mm pockets, mobile upper molars and bone loss past half the root length. The discrepancy is the lesson: nicotine-constricted vessels do not bleed readily, so bleeding percentages understate his disease and attachment loss has advanced quietly — interpret depths and radiographs with greater weight. Phase I debridement proceeds as for any patient, but counselling begins on day one with the dose history in pack-years — ask, advise, assess, assist with a quit date and pharmacotherapy referral, arrange follow-up — every procedure's prognosis hangs on it. At the six-week re-evaluation expect less improvement than a non-smoker with identical depths — evidence-based, not pessimism, and shared honestly before surgery rather than after a disappointing graft. His recall is three-monthly, surgical options are sequenced with the quit attempt, and his smokeless-tobacco-using brother — recession and a white patch where the khaini sits — gets a biopsy-minded examination and the same cessation conversation. The smoker's mouth teaches that periodontal therapy that ignores tobacco treats the disease's junior partner only.
Ask, advise, arrange
The theory answer is list-like; the viva wants integration. "Why does a smoker's gum bleed less despite more disease?" — vasoconstriction plus reduced crevicular flow, with the consequence that bleeding percentages mislead in this group. Expect the healing question — smokers gain less after surgery and regeneration — with the practical answer that elective regenerative surgery in an unremitting heavy smoker is often deferred. The Indian dimension: smokeless tobacco produces site-specific recession, attachment loss and mucosal lesions, so ask about the habit by product name; patients who deny cigarettes may still place tobacco in the sulcus daily. Finally, the 5As turn a lecture into a documented clinical procedure, and examiners reward stating that quitting improves prognosis and partially reverses risk.
Frequently asked questions
Why do smokers show less gingival bleeding despite more severe disease?
Nicotine-mediated vasoconstriction with reduced gingival blood flow and crevicular fluid blunts erythema, oedema and bleeding on probing, masking the inflammation underneath.
How does smoking impair periodontal healing?
It suppresses fibroblast proliferation and collagen synthesis, impairs neutrophils, constricts mucosal blood supply and dampens immunity, yielding smaller attachment gains and more implant and graft failures.
Does the risk fall after quitting?
Yes — former smokers carry risk intermediate between current and never-smokers, and cessation before periodontal or implant surgery measurably improves healing outcomes.
What periodontal effects does smokeless tobacco cause at the placement site?
Localised recession, attachment loss and pocketing where the quid sits, with leukoplakia and oral submucous fibrosis as mucosal sequelae — reasons to ask about gutkha, paan masala and khaini by name.
What is the 5A approach to tobacco cessation?
Ask about tobacco use at every visit, advise quitting clearly and personally, assess willingness to quit, assist with a quit plan and referral, and arrange follow-up — a documented clinical procedure rather than casual advice.